Arbor Investment Advisors »

Halozyme Therapeutics shares owned by Arbor Investment Advisors

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Arbor Investment Advisors from 13F filings

Historical chart of Arbor Investment Advisors investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Arbor Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Arbor Investment Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.0M 18k 57.24
2024-03-31 $730k 18k 40.68
2023-12-31 $663k 18k 36.96
2023-09-30 $686k 18k 38.20
2023-06-30 $648k 18k 36.07
2023-03-31 $686k 18k 38.19
2022-12-31 $1.0M 18k 56.90
2022-06-30 $790k 18k 44.01
2022-03-31 $716k 18k 39.89
2021-12-31 $722k 18k 40.22
2021-09-30 $730k 18k 40.67
2021-06-30 $815k 18k 45.40
2021-03-31 $748k 18k 41.67
2020-12-31 $767k 18k 42.73
2020-09-30 $472k 18k 26.30
2020-06-30 $481k 18k 26.80
2020-03-31 $323k 18k 17.99
2019-12-31 $318k 18k 17.72
2019-09-30 $278k 18k 15.49
2019-06-30 $308k 18k 17.16